0001209191-20-043484.txt : 20200723 0001209191-20-043484.hdr.sgml : 20200723 20200723163317 ACCESSION NUMBER: 0001209191-20-043484 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200721 FILED AS OF DATE: 20200723 DATE AS OF CHANGE: 20200723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Legault Pierre CENTRAL INDEX KEY: 0001391045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38667 FILM NUMBER: 201043970 MAIL ADDRESS: STREET 1: P.O. BOX 1028 STREET 2: C/O STONE MANAGEMENT LLC CITY: BERWYNE STATE: PA ZIP: 19312 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Urovant Sciences Ltd. CENTRAL INDEX KEY: 0001740547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 BUSINESS PHONE: 949-226-6029 MAIL ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-21 0 0001740547 Urovant Sciences Ltd. UROV 0001391045 Legault Pierre C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617 1 0 0 0 Common Shares 2020-07-21 4 A 0 9000 0.00 A 21480 D Stock Option (Right to Buy) 9.38 2020-07-21 4 A 0 15000 0.00 A 2030-07-21 Common Shares 15000 15000 D The Restricted Stock Units shall vest on July 21, 2021, subject to the Reporting Person providing continuous service to the Issuer through such vesting date. The shares underlying the option shall vest and become exercisable on July 21, 2021, subject to the Reporting Person providing continuous service to the Issuer through such vesting date. /s/ Bryan Smith, Attorney-in-Fact 2020-07-23